Background: PHO85 encodes the catalytic subunit of a cyclin-dependent kinase (Cdk) in budding yeast and functions in phosphate and glycogen metabolism. Pho85 associated with the G1 cyclins Pcl1 and Pcl2 is also required for cell cycle progression in the absence of the Cdc28 cyclins Cln1 and Cln2. Loss of Pcl1, Pcl2 and related Pho85 cyclins results in budding defects, suggesting that Pcl-Pho85 complexes function in cell morphogenesis early in the cell cycle; their precise role is not clear, however.
Background
In the budding yeast Saccharomyces cerevisiae, commitment to the cell cycle occurs in late G1 phase once cells reach a critical cell size; this commitment phase is known as 'Start' and is analogous to the restriction point in mammalian cells [1] . Cell cycle transitions, including Start, are governed by members of a highly conserved family of proteins called cyclin-dependent kinases (Cdks). As their name implies, Cdk activation requires binding of a positive regulatory subunit called a cyclin. Like Cdks, cyclins form a large family of related proteins that share sequence homology in a region called the 'cyclin box' that is required for Cdk interaction [2] . The Cdc28 protein is the major cell cycle regulatory Cdk in budding yeast. At Start, Cdc28 associates with the G1 cyclins, Cln1, Cln2 and Cln3, to promote cell cycle commitment. After Start, progression through subsequent phases of the cell cycle (S-phase and mitosis) depends on activation of Cdc28 by other cyclins called Clbs [1] .
Recent work, largely in yeast, has shown that Cdk complexes not only promote cell cycle transitions but also function to regulate gene expression and other cellular processes [3] . PHO85 encodes a multifunctional Cdk in budding yeast that is 51% identical to Cdc28 [4] . Although PHO85 is not an essential gene, pho85 mutant strains show a broad spectrum of phenotypes, indicating many cellular roles for Pho85 Cdk complexes. Consistent with the multifunctional nature of Pho85, 10 genes encoding known or putative Pho85 cyclins (Pcls) have been identified [5] . The Pho85 cyclins have been divided into two subfamilies based on sequence similarity within the cyclin-box region [3, 5] . The Pho80 subfamily is composed of Pho80, Pcl6, Pcl7, Pcl8 and Pcl10. The in vivo substrates of three Pho80 subfamily kinases have been identified. When complexed with Pho80, Pho85 controls expression of the major acid phosphatase gene, PHO5, by phosphorylating Pho4, a basic-helix-loop-helix transcription factor [6] . Two other members of the Pho80 subfamily, Pcl8 and Pcl10, convey Pho85 kinase activity towards Gsy2, the major isoform of glycogen synthase, both in vivo and in vitro [7] .
The five remaining Pho85 cyclins are related to Pcl1 and Pcl2, and form a second subfamily known as the Pcl1,2 subfamily [5] . The biological substrates for these cyclin complexes are not known, but a number of observations suggest a role for Pcl1,2-type kinases in regulating early cell cycle events. First, although strains deleted for PCL1 and PCL2 are viable, Pcl1,2-Pho85 kinases are required for G1 phase progression in the absence of the Cdc28 cyclins CLN1 and CLN2 suggesting a role for Pcl1,2-Pho85 kinases at Start [8, 9] . Second, expression of three members of the Pcl1,2 subfamily is cell cycle regulated, with peak expression in early or late G1 phase [5, 10, 11] . Third, yeast strains lacking the entire Pcl1,2 subfamily show morphological and budding defects that include elongated buds, connected chains of cells and a random budding phenotype in diploids [5, 11] . These observations suggest that Pcl1,2-Pho85 kinases function to regulate aspects of cell morphogenesis and budding early in the cell cycle, a contribution that becomes essential when other G1 regulators are compromised.
Proper cell morphogenesis and bud emergence requires a marked polarization of growth and secretion and is dependent on the dynamic function of the actin cytoskeleton, which undergoes rearrangements throughout the cell cycle [12] . The spectrum of phenotypes seen in actin mutants has revealed functions for the actin cytoskeleton in polarized cell growth and secretion, budding and bud site selection, endocytosis, sporulation and cytokinesis [12] . Two related genes, RVS161 and RVS167, function in actin cytoskeleton regulation and were first identified in a screen for mutations that caused reduced viability on starvation (rvs mutants [13] ). Deletion of RVS161 or RVS167 leads to a similar spectrum of phenotypes, suggesting a role for the RVS genes in regulation of the actin cytoskeleton in response to varying nutrients or stress. The phenotypes associated with deletion of the RVS genes include the following: first, loss of viability and unusual cell morphology in poor growth media or salt-containing media; second, delocalized actin distribution under suboptimal growth conditions [13] [14] [15] ; third, abnormal (random) budding in diploids [13, 14] ; fourth, a defect in endocytosis [16] ; and fifth, poor sporulation [17] . Other observations suggest that Rvs161 and Rvs167 bind actin or actin-associated proteins. For example, Rvs167 interacts with actin in a yeast two-hybrid interaction assay and binds the same subset of actin mutants as profilin, a regulator of actin assembly [18] . The interaction of Rvs167 with actin may be indirect as Rvs167 also binds directly to the actinbinding protein Abp1 in vitro [19] .
Rvs167 is composed of three predicted protein-protein interaction domains. First, Rvs167 contains a carboxy-terminal Src homology 3 (SH3) domain that is required for both the interaction with actin in the two-hybrid assay and for binding to Abp1 in vitro [18, 19] . Second, in Rvs167 the SH3 domain is preceded by a region rich in glycine, proline and alanine called the GPA domain; similar regions are found in other actin-associated proteins such as myosin I and Abp1 [13] . Third, the aminoterminal region of Rvs167 and the entire Rvs161 protein has been dubbed the RVS or BAR (Bin1-Amphiphysin RVS) domain [13, 15, [20] [21] [22] . Within the BAR/RVS region are sequences predicted to form two coiled-coil structures [23] . Thus, the predicted structure of Rvs167 suggests that it can interact with multiple proteins through distinct domains.
In this paper, we report the results of genetic and biochemical experiments that implicate Rvs167 as a target of Pcl1,2-Pho85 Cdk complexes in vivo. We identify Rvs167 as a protein that can interact with Pcl2 and related cyclins both in vivo and in vitro. We propose that interaction of Rvs167 and Pcl-Pho85 Cdks contributes to actin cytoskeleton regulation early in the cell cycle.
Results

Interaction of Pcl2 and Pcl9 with Rvs167 in a two-hybrid assay
To identify targets or regulators of Pcl-Pho85 kinase complexes, we used yeast two-hybrid screens to search for proteins that interacted with the related Pho85 cyclins Pcl2 and Pcl9 [5] . The two-hybrid screen with Pcl2 has been previously described and led to the identification of Pho85 as the Cdk partner for Pcl2 [8] . For the Pcl9 screen, library transformants were screened using the yeast strains described by James et al. [24] . We identified multiple independent isolates of Rvs167 from both genomic and cDNA libraries tagged with the Gal4 activation domain (AD) in the Pcl2 and Pcl9 screens. Quantitative β-galactosidase assays showed that the interaction of Pcl2 with the largest Rvs167-AD fusion identified in the screen resulted in close to 400-fold stimulation of reporter gene expression (pAD-RVS167∆11, Table 1 ). The fusion protein encoded by this RVS167-AD isolate lacked the first amino-terminal 11 amino acids of Rvs167. Activation of the reporter gene was also seen with the Gal4 DNAbinding domain (DB) fusion protein DB-Pcl9 and AD-Rvs167∆11 (Table 1) . In this case, activation of the reporter gene was not as pronounced as that seen with Pcl2. This result may reflect the fact that the DB-Pcl9 fusion protein was expressed from a crippled promoter [24] . Because Rvs167 binds actin and Apb1 via the carboxy-terminal SH3 domain [18, 19] , we tested interaction of an Rvs167-AD fusion lacking the SH3 domain with Pcl2 and Pcl9 in the two-hybrid system ( Table 1) . The SH3 domain of Rvs167 was not required for interaction of Pcl2 or Pcl9 with Rvs167 indicating that binding of the cyclins to Rvs167 requires a region distinct from that required for interaction with actin and Abp1.
Association of Rvs167 and Pcl2 in vitro and in yeast lysates
To corroborate the Rvs167-Pcl2 two-hybrid interaction, we used two assays to test for complex formation in vitro. First, in vitro translated Pcl2 and Pho85 were tested for binding to glutathione-S-transferase (GST)-Rvs167 ligands in a batch affinity chromatography assay ( Figure 1a and data not shown). When Pcl2 was incubated with a full-length GST-Rvs167 ligand, over 50% of the Pcl2 was specifically retained on the resin (Figure 1a, lanes 3-6 ). An Rvs167 ligand lacking the carboxy-terminal SH3 domain also bound Pcl2 effectively ( Figure 1a, lanes 7,8) . By contrast, Pho85 failed to bind to Rvs167 above background in the batch affinity chromatography assay (data not shown).
We used a second biochemical assay to confirm an association between Pcl2 and Rvs167. Immunoprecipitation of Pcl2 from yeast extracts with polyclonal Pcl2 antiserum [8] followed by immunoblotting with Rvs167 antibodies revealed an association between Pcl2 and Rvs167 ( Figure 1b, lanes 2,4) . The Pcl2-Rvs167 interaction was not detected in extracts from pcl2∆ strains (Figure 1b , lane 6) confirming the specificity of the Pcl2-Rvs167 interaction. Consistent with our batch affinity chromatograph assay, we were also able to detect coimmunoprecipitation of Pcl2 and Rvs167 in extracts from a pho85 deletion strain (data not shown). Reproducible detection of the association between Pcl2 and Rvs167 in yeast extracts required overproduction of Rvs167 ( Figure 1b) ; this is probably due to the small amount of Pcl2 that can be immunoprecipitated from yeast extracts and the sensitivity of the immunoprecipitation-western assay. We were unable to use an Rvs167 immunoprecipitation reaction to look at associated Pcl2 protein because Pcl2 is not routinely visible on western blots from yeast extracts using our antiserum. In any case, three independent assays (twohybrid, coimmunoprecipitation and GST pull-down) all show interaction between Rvs167 and Pcl2. The assays indicate that Pcl2 interacts directly with Rvs167 and that the interaction is independent of the Rvs167 SH3 domain.
The rvs167, pho85 and pcl mutant strains show similar phenotypes To begin to assess the relevance of the Pcl-Rvs167 interaction in vivo, we examined the phenotypes of pho85 and pcl mutant strains in light of the known defects of rvs167 Yeast strains transformed with a plasmid expressing a Pcl2 (pAS1-PCL2) or Pcl9 (pGBD-PCL9) fusion to the Gal4-DB or expressing the Gal4-DB alone (pAS1 or pGBD) were mated with strains transformed with Gal4-AD (pAD) constructs. Plasmids pAD-RVS167∆11 and pAD-RVS167∆SH3 express AD-Rvs167 fusion proteins. Data are the average of two to three independent transformants. *Values are given as Miller Units of β-galactosidase, as defined [5] . † Relative to the pAS1 or pGBD control. mutants. We previously reported that, like rvs167 mutants [13, 15] , pho85 and pcl mutant strains show a random budding phenotype in diploid cells [11] . We next assessed pho85 and pcl mutants for an endocytotic defect, another mutant phenotype seen in rvs167 mutants under standard growth conditions [16] . To determine if loss of Pho85 or Pcl1,2-type cyclins abolished endocytosis, we assayed fluid-phase endocytosis of lucifer yellow in pho85 and pcl1 pcl2 pcl5 pcl9 clg1 (quintiple pcl deletion; quint∆) mutant strains. We chose to assay mutant phenotypes in strains lacking all Pcl1,2 subfamily members because our previous studies indicate some functional redundancy among the PCL genes [5, 11] . The pho85, pcl and rvs167 mutant cells all had a vacuolar compartment of at least wild-type size as viewed with Nomarski optics (Figure 2 ). However, fluorescence microscopy revealed that, like rvs167 mutants, both pho85 and the pcl mutants were defective for lucifer yellow accumulation in the vacuole (Figure 2 ).
Phenotypes for pho85 and pcl mutant cells were also evident in certain stress conditions that compromise the growth of rvs167 mutants. We used a plating assay to compare the growth of wild-type, rvs167, pho85 and pcl mutant cells on medium containing 6% sodium chloride ( Figure 3 ). Wildtype, pcl2∆ and pcl2∆ pcl9∆ strains were able to form colonies on the high salt medium ( Figure 3 , compare YPDS versus YPD). By contrast, a strain lacking Pho85 or the Pcl1,2-type cyclins ( Figure 3 , quint∆) failed to grow on the salt-containing medium. The salt sensitivity seen in these mutant strains was comparable to that seen in the isogenic strain deleted for RVS167. We also assayed the same series of strains for cell viability and morphology after starvation in carbon-limiting medium. As previously reported for rvs167 mutants [13] , we found that pho85∆ and pcl mutant cells were of various sizes and showed an unusual morphology upon starvation with many large, swollen cells visible in the culture (data not shown). In the pho85 and pcl mutants, a significant reduction in cell viability after starvation was also seen (data not shown). In our strain background, however, we saw only a slight decrease in cell viability after starvation for the rvs167 mutant, in contrast to previous reports [13] (data not shown). We presume that this discrepancy reflects differences in strain background. In summary, our phenotypic analysis revealed new phenotypes for strains lacking Pcl1,2-type Pho85 kinases that are shared with rvs167 mutants and many other mutants with defects in actin function. Our genetic evidence suggests that the Rvs167-Pcl2 interaction that we detected in two-hybrid and biochemical assays reflects a common function for Rvs167 and the Pcl1,2-Pho85 Cdks in vivo.
Actin organization defects in pho85 and pcl mutant strains
Because the phenotypic defects shared between rvs167, pho85 and pcl mutants are often associated with defects in actin cytoskeletal function, we asked whether pho85 and pcl mutants showed a loss of actin organization as previously reported for rvs167 mutants [13] [14] [15] . In yeast, the actin cytoskeleton consists of cortical patches and cables and the distribution of these structures varies through the cell cycle [12] . Cortical actin patches concentrate in the bud during early bud emergence and, in general, are concentrated at sites of surface growth. Figure 4 shows examples of actin localization in budded cells in wild-type, rvs167∆, pho85∆ and pcl mutant strains. Strains were grown in rich medium or in salt-containing medium, and the actin cytoskeleton was visualized with rhodamine-conjugated phalloidin. The salt concentration we chose for this experiment (3% NaCl)
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Figure 2
Assay of endocytosis in cultures of wild-type, rvs167∆, pho85∆ and pcl1∆pcl2∆clg1∆pcl5∆pcl9∆ cells. Fluid-phase endocytosis was assayed using lucifer yellow (LY) on the following haploid strains: wildtype (WT, BY261), rvs167∆ (BY508), pho85∆ (BY391) and quint∆ (pcl1∆pcl2∆clg1∆pcl5∆pcl9∆, BY714). Lucifer yellow accumulation was visualized with fluorescein isothiocyanate (FITC) fluorescence optics and photographed at a magnification of 630× using an imaging system (see Materials and methods). Photographs of the same field of cells viewed with Nomarski optics (differential interference contrast) are shown to the right. was previously shown to exacerbate the actin delocalization phenotype of rvs167 and rvs161 mutants [13, 15] but still allowed continued growth of the strains. To assess actin cytoskeletal polarity, we looked at the distribution of actin patches in budded cells in the culture and scored cells as polarized (bright staining patches in daughter cell, very little staining in mother cell), partially depolarized (some concentration of actin patches in daughter cell, but obvious staining in mother cell) or depolarized (random distribution of actin patches between mother and daughter cells). As expected, most wild-type cells showed polarized cortical actin patches in the growing bud even in salt-containing medium (96% of small-to-medium budded cells with localized actin patches, n = 50, Figure 4 ). As previously reported [13] , however, a significant fraction of rvs167∆ cells showed delocalized actin patches with a random distribution of patches between mother and bud (40% of cells with partially delocalized actin patches, 60% delocalized in budded cells, n = 50). The actin delocalization in the rvs167∆ cells was more pronounced following salt treatment (100% delocalized actin patches in budded cells, n = 50). In rich medium, we observed that 86% of budding pho85 mutant cells had partial actin delocalization with visible actin patches in the mother cells but with some brighter actin staining in the growing bud (n = 50). The remainder of the budding pho85 mutant cells in the culture showed completely delocalized actin patches. The strain lacking all Pcl1,2-type cyclins (quint∆, Figure 4 ) showed delocalized actin patches in virtually all cells in the population although some concentration of actin was seen at the tips of many of the abnormal buds in this strain. Like the rvs167 mutant, the actin organization defect of the pho85 and pcl mutant cells was more pronounced in medium containing salt. In some cells, the morphological abnormalities associated with loss of Pho85 or the Pcl1,2-type cyclins made assessment of the actin phenotype difficult. Nonetheless, it was clear that, like rvs167 mutants, pho85 and pcl mutant cells show abnormalities in the actin cytoskeleton.
Phenotypic consequences of Rvs167 overexpression
To develop strains for studying protein complexes containing Rvs167, we constructed a yeast expression vector in which Rvs167 was overexpressed from the inducible galactose promoter (pGAL-RVS167). Western blot analysis using anti-Rvs167 antiserum showed that Rvs167 was significantly overexpressed in transformants expressing RVS167 from pGAL-RVS167 (for example, see later). To determine if overexpression of Rvs167 caused a cellgrowth phenotype, we plated haploid cells transformed with pGAL-RVS167 on non-inducing medium (dextrose) or on medium containing galactose to induce high level expression of RVS167 (Figure 5a ). Overexpression of Effects of salt stress on the growth of rvs167∆, pho85∆ and pcl∆ strains. Growth of wild-type (WT), rvs167, pho85, pcl2 and multiple pcl strains on medium containing sodium chloride. Serial dilutions of log phase cultures of the following strains were plated on YPD or YPDS (6% NaCl) media: wild-type (BY263), rvs167∆ (BY508), pho85∆ (BY391), pcl2∆ (BY344), pcl2∆ pcl9∆ (BY697) and quint∆ (pcl1∆pcl2∆clg1∆pcl5∆pcl9∆, BY714). Plates were incubated at 30°C for 5 days and photographed. Actin localization in wild-type, rvs167∆, pho85∆ and pcl∆ cells. Cells were grown in rich medium (YPD) or in rich medium with 3% NaCl (YPDS), fixed, and the actin stained using rhodamine-conjugated phalloidin as described in Materials and methods. Examples of actin localization in the following diploid cells are shown: wild-type (WT, BY264), rvs167∆ (BY561), pho85∆ (BY868) and pcl1∆pcl2∆clg1∆pcl5∆pcl9∆ (quint∆, BY730). Rvs167 caused a slow-growth phenotype and abnormal cell morphology when cells were grown at 30°C and caused growth arrest at 37°C (Figure 5a,c) . Interestingly, the slowgrowth phenotype caused by Rvs167 overexpression was exacerbated by loss of Pho85 (Figure 5b ) or the Pcl1,2-type cyclins (data not shown). This type of genetic interaction has been termed 'synthetic dosage lethality' and has been used to identify genes encoding functionally interacting proteins [25] . Our observations are consistent with a model in which Rvs167 participates in a protein complex or regulatory process that is disrupted by overexpression of Rvs167; the perturbation of Rvs167 function in this context is enhanced by the absence of Pcl1,2-Pho85 kinases.
Phosphorylation of Rvs167 by Pcl-Pho85 kinases
The biochemical and genetic interactions that we detected between Pcl kinases and Rvs167 suggested that Rvs167 may be a substrate of Pcl-Pho85 kinases. We tested this possibility by preparing purified recombinant Rvs167 protein to use as a substrate in Pcl-Pho85 kinase assays. The Pho80/Pho85-dependent phosphorylation sites on the Pho4 transcription factor have been mapped [26] and define a consensus for phosphorylation (S/T-P-Xhydrophobic; in single-letter amino acid code where X is any amino acid) whereas a slightly different target site for the Pcl10-Pho85 kinase has been defined on the Gsy2 protein (S/T-P-X-D; [7] ). Based on these consensus sequences, Rvs167 contains several potential Pho85 phosphorylation sites clustered near or in the SH3 domain in the carboxyl terminus of the protein (S379, S390, S407, T412 and T454).
Truncation derivatives of Rvs167 containing one or more of these putative Pho85 phosphorylation sites were purified as GST fusions from bacterial cells and incubated with Pcl2-Pho85 in the presence of radiolabelled ATP. All Rvs167 protein derivatives were specifically phosphorylated by Pcl2-Pho85 in the in vitro kinase reaction while GST alone was not phosphorylated in the reaction ( Figure 6 ). We were also able to detect phosphorylation of the purified full-length GST-Rvs167 fusion protein that we used in our affinity chromatography experiments in Figure 1 (data not shown). We were able to recover only very small amounts of full-length protein from the glutathione-sepharose beads, however, and the signal obtained in the kinase assays with the truncated derivatives of Rvs167 was much stronger. We conclude that Rvs167 is a substrate for Pcl2-Pho85 kinase in vitro.
Next, we asked whether phosphorylation of Rvs167 was dependent on Pcl-Pho85 kinases in vivo. We assayed phosphorylation of Rvs167 in two ways. First, when Rvs167 immunoprecipitates (Figures 7a,8a) 
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Importantly, we found that phosphorylation of Rvs167 was partially dependent on Pcl-Pho85 kinases in vivo. Rvs167 immunoblots of extracts or Rvs167 immunoprecipitates from pho85∆ or pcl∆ strains showed that the phosphorylated isoforms of Rvs167 were reduced in the extracts from the pcl or pho85 mutant strains (Figure 8a , compare lanes 2-4). The slower migrating phosphoforms of Rvs167 sometimes appeared to migrate as a single band (as in Figure 8a ) but they often resolved into multiple species showing that Rvs167 is phosphorylated on multiple sites. For example, the multiple Rvs167 isoforms were clearly visible in the immunoblots of log-phase extracts from wildtype cells shown in Figure 8b (lane 1). Again, some, but not all, of the phosphoforms were absent in extracts from the multiple pcl mutant strain (Figure 8b, lane 5) . Thus, the reproducible reduction in Rvs167 phosphorylation that we see in the pho85 and pcl mutant strains suggests that phosphorylation at certain sites on the Rvs167 protein is dependent on Pcl-Pho85 kinases in vivo. Our data clearly suggest that other kinases also phosphorylate Rvs167.
As a further test of the dependence of Rvs167 phosphorylation on Pcl-Pho85 kinases in vivo, we examined Rvs167 phosphoforms in cells treated with α factor, a pheromone that arrests cells at Start in preparation for mating. PCL2 transcript is induced rapidly in response to α factor, and the associated Pcl2-Pho85 kinase activity also increases during pheromone-mediated arrest [8] . Interestingly, we found that Rvs167 was hyperphosphorylated in pheromone-treated cell extracts (Figure 8b, lane 2) . In a pcl2∆ strain, the pheromone-dependent phosphorylation was clearly reduced; some Rvs167 isoforms appeared to be entirely Pcl2 dependent whereas others were maintained in the pcl2∆ strain (Figure 8b, compare lanes 2 and 4) . Equal loading of cell extracts in this experiment was ensured by quantitation of total protein in the extract and a control immunoblot with an unrelated antiserum (antiSwi6, data not shown). No further reduction in the α-factor-dependent Rvs167 phosphorylation was seen when other Pcl1,2-type cyclins were also absent (quint∆; Figure 8b , compare lanes 4 and 6). Thus, in contrast to the situation in log-phase cells, other Pcl1,2-type cyclins were unable to compensate for the absence of Pcl2 to phosphorylate Rvs167 in response to α-factor treatment. Rather, the Pcl2-dependent induction of Rvs167 phosphorylation in response to pheromone mirrored the induction of Pcl2-Pho85 kinase [8] . Together, our in vivo and in vitro data implicate Rvs167 as a substrate of Pcl-Pho85 kinases.
Discussion
Pho85 encodes a multifunctional protein kinase that has roles in regulating cell metabolism and division [3] . Pho85 is thought to carry out its many functions through association with different Pho85 cyclins, or Pcls, of which ten are known [5] . Genetic studies and gene expression analysis have implicated Pho85 Cdk complexes in regulating early cell cycle progression and cell morphogenesis when complexed with members of the Pcl1,2-type cyclins [5, 11] . In this paper, we describe several new phenotypes of pho85 and pcl1,2-subfamily mutants that suggest a defect in actin cytoskeleton function. In two-hybrid screens with Pcl2 and Pcl9, we identified RVS167, a gene previously shown to be important for endocytosis, cell survival after starvation, and actin cytoskeletal organization. We found that Rvs167 was phosphorylated by Pcl2-Pho85 kinase in vitro and that phosphorylation of Rvs167 was partially dependent on Pcl-Pho85 kinases in vivo. Together, these data suggest that regulation of Rvs167 by Pcl-Pho85 Cdks may contribute to control of actin cytoskeleton rearrangements early in the cell cycle.
Interaction of Pcl1,2-type cyclins and Rvs167
Two-hybrid, coimmunoprecipitation and GST-Rvs167 binding assays showed that Pcl2 interacts with Rvs167. Therefore, we are confident in our assignment of Pcl2 as an Rvs167-binding protein. We also identified Rvs167 in a screen for proteins that interact with Pcl9, the Pho85 cyclin most closely related to Pcl2 (64% identical [5, 11] ). In fact, all members of the Pcl1,2 subfamily can interact with GST-Rvs167 in vitro whereas other Pho85 cyclins (the Pho80 subfamily) interact only poorly with Rvs167 in the same assay (L.M., unpublished observations).
Consistent with the ability of all Pcl1,2-type cyclins to bind Rvs167 in at least one in vitro assay, we found genetic redundancy amongst the Pcl1,2-type cyclins in their deletion phenotypes in vivo. Several of the phenotypes that we discovered, such as salt sensitivity and defective endocytosis, were most pronounced when all five members of the Pcl1,2 subfamily were absent. Despite this genetic redundancy for certain phenotypes, two observations indicate that Pcl1,2-type cyclins are likely to have functional distinctions. First, Pcl1 and Pcl2 are required for viability in the absence of the Cdc28 cyclins, Cln1 and Cln2 [8] . In this particular genetic circumstance, other Pcl1,2-type cyclins cannot substitute for Pcl1 and Pcl2 to allow passage through G1 phase. In the case of Pcl9, which is highly related to Pcl2, the failure to provide the essential Pcl-Pho85 function in the absence of CLN1 and CLN2 might simply reflect the fact that PCL9 expression is at maximal levels in early G1 phase [10, 11] . As such, there may be insufficient Pcl9-Pho85 complexes in late G1 phase to compensate for the absence of Pcl1 and Pcl2. Second, in α-factor-arrested cells, we observed phosphorylation of Rvs167 that was dependent on Pcl2 but independent of the other Pcl1,2-type cyclins. The dependence of Rvs167 phosphorylation on Pcl2 during α-factor treatment is likely to reflect the induction of PCL2 expression and Pcl2-Pho85 kinase activity that occurs after pheromone treatment [8] . As neither pcl2 nor rvs167 mutants have a significant defect in the pheromone response, the biological importance of Rvs167 hyperphosphorylation in response to α factor is as yet unclear. In contrast to PCL2, levels of PCL1 transcript decrease rapidly in response to pheromone and PCL9 transcript levels also decrease because of the timing of PCL9 expression [10, 11] . We suggest that the highly related G1-specific Pho85 cyclins, Pcl1, Pcl2 and Pcl9, normally function in aspects of actin regulation distinct from the more distantly related cyclins (Clg1, Pcl5). Our data indicate that one aspect of this function involves the phosphorylation and regulation of Rvs167. The dramatic morphological abnormalities associated with deletion of the Pcl1,2-type cyclins also suggest that other substrates of Pho85 may also be involved in regulating cell morphology and the cytoskeleton. A test of these ideas will require the development of kinase assays for other Pcl1,2-type cyclins and the identification of other targets of Pho85 kinases related to actin regulation and G1 progression in addition to Rvs167.
Rvs167 and Pcl-Pho85 kinases as components of protein complexes regulating the actin cytoskeleton
We have accumulated genetic and biochemical results that implicate Rvs167 as a target of Pcl1,2-type Pho85 kinases and suggest a role for these Cdks in actin cytoskeleton regulation early in the cell cycle. What properties of Rvs167 might be regulated by Pho85 kinases? Phosphorylation of Rvs167 by Pcl-Pho85 kinases might influence the interaction of Rvs167 with other actin regulatory proteins. Specifically, a number of genetic and some biochemical observations suggest that Rvs167 interacts with the actinbinding protein Abp1 to regulate the actin cytoskeleton. First, as noted in the Background, the SH3 domain of Rvs167 is required for interaction with actin in a twohybrid assay [18] . Abp1 binds directly to the Rvs167 SH3 domain in vitro, however, suggesting that the interaction of Rvs167 with actin may be indirect [19] . Second, deletion of either RVS167 or ABP1 does not cause a dramatic growth defect in standard conditions, and an rvs167 abp1 double mutant shows no additional phenotypes. The rvs167 and abp1 mutants, however, show the same profile of synthetic lethal interactions with genes encoding other cytoskeletal components including SRV2, SLA1, SLA2/END4 and SAC6 [19] . Third, overexpression of ABP1 [19, 27] or RVS167 (this paper) causes morphological abnormalities and temperature sensitivity. In the case of ABP1 overexpression, the growth defect is suppressed by deletion of RVS167 suggesting that misregulation of Rvs167 may be contributing to the Abp1 overexpression phenotype [19] .
Together, these data suggest that Rvs167 and Abp1 may form a complex that functions to control the actin cytoskeleton in response to various stresses, a function that becomes essential in the absence of other cytoskeletal proteins. The potential Pho85 phosphorylation sites in Rvs167 all cluster near or in the SH3 domain (Figure 6c ). One putative Pho85 phosphorylation site, T454, resides within the SH3 domain and is probably phosphorylated in vitro by Pcl2-Pho85 kinase (Figure 6b) . Alignment of the SH3 domain of Rvs167 with SH3 domains from other proteins shows that T454 lies within the so-called 'n-Src loop' that is involved in ligand binding in other SH3 domains (Alan Davidson, personal communication) [28] . Phosphorylation of T454 by Pcl2-Pho85, and perhaps other sites amino terminal to the SH3 domain, might regulate the interaction of Abp1 with the SH3 domain of Rvs167.
In addition to binding Abp1, Rvs167 has been implicated in interactions with other actin regulatory proteins. As noted above, a significant function of the SH3 domain of Rvs167 is probably to interact with Abp1. Other proteins may also interact with the SH3 domain or other regions of Rvs167. For example, a protein interaction involving Rvs167 has been suggested by two-hybrid experiments showing an interaction between Rvs167 and a central coiled-coil domain in the actin regulatory protein Sla2/End4 [29] . Interestingly, the coiled-coil domain of the Sla2/End4 protein has an endocytic function that is redundant with Abp1 and the Abp1-binding protein, Srv2 [29] . These observations prompted the hypothesis that a common function of End4, Abp1 and Srv2 involves direct or indirect interaction with Rvs167 [29] .
Like Sla2/End4, Rvs167 is predicted to contain alphahelical coiled-coil structures within its amino-terminal BAR/RVS region [15] . Two-hybrid and coimmunoprecipitation experiments have shown that Rvs161, which is composed only of a BAR region, can interact with Rvs167 [23] . Recent work suggests that Rvs161 is not always complexed with Rvs167, however. Alleles of RVS161 have been identified that are specifically defective in either endocytosis or cell fusion [30] . The organization of the actin cytoskeleton was not impaired in the cell fusion mutants, showing that the function of Rvs161 in cell fusion is independent of its role in actin regulation. As Rvs167 is not required for cell fusion [30] , it is unlikely to participate in protein complexes with Rvs161 during mating. In any case, phosphorylation of Rvs167 by Pcl-Pho85 may serve to influence the association of Rvs167 with Abp1, Rvs161, Sla2/End4 or other proteins either by direct regulation of the interaction between the proteins or by influencing their subcellular localization. As not all phosphorylation on Rvs167 is dependent on Pho85, other kinases may also influence the formation of protein complexes involving Rvs167. A test of this model will require an analysis of the phenotypic consequences of mutating the phosphorylation sites on Rvs167 and study of the subcellular localization of Rvs167 and Pcls. It is important to note that deletion studies have shown that derivatives of Rvs167 lacking the SH3 domain are able to complement several rvs167 mutant phenotypes ( [15] , K.C., unpublished observations). As our work and other studies suggest an important role for the Rvs167 SH3 domain, we suspect that the subtle phenotypic consequences of deleting the SH3 domain of Rvs167 reflect the overlapping functions of components of the actin cytoskeleton.
Conservation of regulatory pathways involving Rvs-and Pho85-like proteins
Our studies of Pho85 and Rvs167 might define a conserved regulatory pathway involving regulation of cell morphogenesis and polarity by Cdks. Two mammalian homologues of Rvs167, called amphiphysin I and amphiphysin II, have been identified [31] . Like Rvs167, amphiphysins contain an amino-terminal BAR/RVS domain and a carboxy-terminal SH3 domain. Amphiphysins are involved in endocytosis during synaptic vesicle recycling at presynaptic nerve terminals and bind to proteins required for endocytosis such as dynamin and clathrin [31] . Recently, amphiphysin I was shown to colocalize with actin and dynamin in the growth cones of developing neurons. Also, depletion of amphiphysin I using antisense oligonucleotides leads to growth-cone collapse, implicating amphiphysin I in interactions with actin or actin-binding proteins to promote cytoskeletal polarization during neuronal outgrowth [32] . Amphiphysin I is dephosphorylated after depolarization of nerve terminals and phosphorylation of amphiphysin affects its interaction with proteins involved in clathrinmediated endocytosis [33] [34] [35] [36] . Thus, like the Rvs proteins in yeast, amphiphysins appear to be regulated by phosphorylation and are involved in controlling endocytosis and actin cytoskeletal function.
Interestingly, Pho85 is most similar to mammalian Cdk5 which, like Pho85, has important non-mitotic roles. Cdk5 associates with a neuronal-specific activator, p35, and has been proposed to play a regulatory role in cytoskeletal dynamics and neuronal differentiation [37] . Like amphiphysin, Cdk5 colocalizes with actin in the growth cones of developing neurons and is involved in neural outgrowth [38] . Whether amphiphysins are direct or indirect targets of Cdk5 remains to be determined.
Conclusions
Rvs167 associates with Pho85 cyclins in two-hybrid assays and in yeast extracts. The phenotypes associated with deletion of pho85 or the pcl1,2 subfamily overlap with those of rvs167 mutants, consistent with a common role for 
Materials and methods
Media and yeast strain manipulations
Plasmids
The pAS1-PCL2 plasmid (pBA668) that was used in the two-hybrid screen has been described [8] . The plasmid expressing a Gal4-DB fusion to PCL9 was constructed by cloning a BamHI fragment containing the PCL9 coding sequence [5] into the BamHI site of the vector pGBD-C2 [24] . Plasmid AD-RVS167∆11 (pBA706) was isolated as a positive interactor in our Pcl2 two-hybrid screen (this paper and [8] ). This construct encodes a Gal4-AD-Rvs167 fusion protein lacking the first 11 amino-terminal amino acids of Rvs167. Plasmid AD-RVS167∆SH3 (pBA822), which expresses a Gal4-AD-Rvs167 fusion protein lacking the first 11 and the last 40 amino acids of Rvs167, was generated by subcloning a blunted XhoI-NaeI fragment from pBA706 into the SmaI site of pACTII. Plasmid pBA837, which carries the fulllength RVS167 gene, was created by PCR amplification from genomic DNA using primers with BglII linkers. The resulting PCR product was cleaved with BglII and cloned into a BglII site of a modified pRS316 vector. Plasmid pGAL-RVS167 was constructed by cloning the BglII fragment of RVS167 from pBA837 into BamHI site of Yep55a. In plasmid pGAL-RVS167, Rvs167 is expressed from the GAL10 promoter and has an additional eight amino acids (MTARSTDL) encoded by linker sequences fused to its amino terminus. Vectors for expressing deletion derivatives of Rvs167 in bacteria were constructed. Plasmid pGst-RVS167∆SH3 (pBA894) encodes a GST-Rvs167 fusion protein lacking the 38 carboxy-terminal amino acids of Rvs167 and was constructed by cloning a BglII-NaeI fragment from pBA837 into the BamHI-SmaI sites of pGEX-1. GST fusions to various subdomains of Rvs167 were constructed by PCR amplification from pBA819 or pBA837 templates, cloning into an intermediate vector (pBA89) and finally subcloning into pGEX-1. Constructs encoding GST fusions to the SH3 domain of Rvs167 (codons 428-482), the GPA domain of Rvs167 (codons 282-427) and the GPA and SH3 domains of Rvs167 (codons 282-482) were constructed in this manner (details of plasmid construction are available on request). All PCR products were sequenced to confirm their integrity. The GST-Rvs167 fusion protein used for antibody production was expressed from plasmid pBA713 which was constructed by ligating a BamHI-BglII fragment from plasmid pBA706 (AD-RVS167-∆11) into the BamHI site of pGEX-1. Plasmid pBA713 encodes a fusion of Rvs167 lacking the first 29 amino-terminal amino acids fused to GST (GST-Rvs167-∆29). The plasmids used as templates for in vitro transcription-translation of Pho85 and His-Pcl2 have been described [8] .
Two-hybrid assay
The two-hybrid screen that identified RVS167 using pAS1-PCL2 has been described [8] . The two-hybrid screen with PCL9 was performed by transformation of yeast strain PJ69-4A [24] with plasmid pGBD-PCL9. This strain was then transformed with the yeast genomic two-hybrid libraries Y2HL-C1, Y2HL-C2 and Y2HL-C3 [24] . A total of 1 × 10 6 colonies from each library were screened for growth on selective media as described [24] . Plasmids from positive clones were then isolated and sequenced. For liquid β-galactosidase assays, yeast (Y153; see Supplementary material) bearing a plasmid expressing a Gal4-DB-Pcl2 fusion (pAS1-PCL2), a Gal4-DB-Pcl9 fusion (pGBD-PCL9), or the Gal4-DB alone (pAS1, [39] or pGBD [24] ) were mated to strain Y187 (see Supplementary material) transformed with plasmids encoding Rvs167 fusions with the Gal4-AD or the Gal4-AD alone (pAD in Table 1 ). Liquid β-galactosidase assays were performed as described [5] .
Batch affinity chromatography assay
GST-Rvs167 fusion proteins for ligands in GST pull-down experiments were isolated from mid-log-phase (1 l) cultures of Escherichia coli NB42 (a lon -strain) harboring the appropriate expression plasmid. Cells were harvested, lysed, and the fusion protein bound to glutathione-sepharose 4B (Pharmacia) as described [5] . For in vitro binding assays, 5 µl Pcl2 translation reaction was incubated with 12.5 µl beads bound with the indicated concentrations of GST, GST-Rvs167, or GST-Rvs167∆SH3, in a total volume of 50 µl buffer D [8] at room temperature for 2 h. The beads were pelleted by gentle centrifugation for 2 min and the 50 µl supernatant was collected and boiled in an equal volume of 2 × SDS sample buffer (unbound fraction, U). The beads were washed four times with 1 ml of RIPA-500 (50 mM Tris-HCl pH 8, 0.1% SDS, 500 mM NaCl, 1% Triton-X-100) buffer, resuspended in 50 µl buffer D plus 50 µl 2 × SDS sample buffer and boiled (bound fraction, B). The unbound and bound fractions were analyzed by 10% SDS-PAGE.
Purification of substrates for in vitro kinase assays
GST and GST-Rvs167-SH3 were prepared by inducing 0.3-1.5 l midlog cultures of E. coli strain DH5α, harboring either plasmid pGEX-1 or pBA1052, with 0.4 mM IPTG for 3 h at 30°C. Cells were harvested and lysed and fusion proteins bound to glutathione-sepharose as recommended (Pharmacia). Proteins were eluted in elution buffer B (20 mM Hepes pH 8, 0.1 mM PMSF, 0.1 mM DTT with the first elution step using 20 mM glutathione, and the second step using 40 mM glutathione). Fractions containing protein were pooled and dialyzed into 20 mM Hepes pH 8, 10% glycerol, 0.1 mM DTT, 0.1 mM PMSF. GST-Rvs167-GPA and GST-Rvs167-GPA-SH3 were purified using a similar protocol. Preparation of yeast extracts for kinase assays and the Pcl2 immunoprecipitation-kinase assay were performed as described [8] , except that 4 mg of cell extract were used to immunoprecipitate the Pcl2-Pho85 complex.
Antibody preparation
Production of anti-Pcl2 antisera has been described [8] . Antibody to Rvs167 was prepared against the antigen GST-Rvs167∆29 encoded by pBA713 (see above). GST-Rvs167∆29 was purified from inclusion bodies, eluted from SDS gels and used to immunize rabbits (Faculty of Medicine, University of Toronto). Antiserum was affinity purified as described [8] .
Protein immunoprecipitation and western blotting
To prepare crude extracts for immunoprecipitation or western blotting, yeast cells were grown to log phase, harvested, washed and quickly frozen in liquid N 2 or on dry ice. Cell extracts were prepared by vortexing cells with glass beads in lysis buffer (0.1% NP-40, 1 mM DTT, 250 mM NaCl, 5 mM EDTA, 50 mM Tris pH 7.5, 1 µM PMSF, 1 µg/ml pepstatin, 1 µg/ml leupeptin, 10 µg/ml soybean trypsin inhibitor, 10 µg/ml N tosyl-L-phenylalanine chloromethyl ketone). For immunoprecipitation, either the affinity purified anti-Pcl2 antibody or anti-Rvs167 antibody were coupled to protein-A-Sepharose beads (Sigma) and added to cell extracts (100 µg total protein in 200 µl lysis buffer for Rvs167 immunoprecipitation; 2.5-3.0 mg total protein for Pcl2 immunoprecipitation). After incubation for 2 h at 4°C, the beads were washed four times with RIPA buffer (50 mM Tris, pH 8, 0.1% SDS, 0.5% deoxycholate, 150 mM NaCl, 1% Triton X-100) or lysis buffer (Pcl2 immunoprecipitation experiment) and boiled in SDS sample buffer. Proteins were separated by 8 or 10% SDS-PAGE and transferred to nitrocellulose using a semi-dry transfer apparatus (BioRad).
Immunoblots were probed with a 1:2000 dilution of affinity-purified Rvs167 antibody, and subsequently with a 1:10 000 dilution of goatanti-rabbit Ig-peroxidase (BioRad). Proteins were visualized using enhanced chemiluminescence (Renaissance detection system, NEN).
To examine Rvs167 isoforms in pheromone-arrested cells, strains were grown in YPD to early log phase. Where specified, α-factor (Vetrogen) was added to 5 µM and the culture was incubated at 30°C for 140 min (95% arrest) before harvesting. Cells were resuspended in an equal volume of 2 × SDS sample buffer without dye (125 mM Tris HCl pH 6.8, 20% glycerol, 4.6% SDS, 10% β-mercaptoethanol) and lysed by agitation in the presence of glass beads. The extracts were boiled for 3 min before centrifugation in a microfuge for 5 min. The protein concentration in the extracts was quantitated by Bradford assay (BioRad) and 10 µg of each extract was resolved by 7.5% SDS-PAGE. Rvs167 was detected as described above for the logphase extracts.
In vivo labeling and phosphatase treatment
Cells were grown to an OD 600 of 0.5 in SD Leu -or SG Leu -medium. Cells were washed twice then resuspended and incubated for 30 min in YPD-Pi or YPG-Pi medium. [ 32 P]orthophosphate was added to 1 mCi per 5 ml culture and cells were labeled for 2 h before harvesting and processing for immunoprecipitation. Samples were resolved by 10% SDS-PAGE and visualized by autoradiography. For phosphatase experiments, Rvs167 immunoprecipitates from yeast extracts were washed three times with RIPA buffer and twice with phosphatase buffer (50 mM Tris pH 8.0, 10% glycerol). The immunoprecipitates were incubated at 37°C for 30 min with 1 unit per 10 µl reaction of calf intestinal phosphatase (Boehringer Mannheim). Where indicated, 50 mM β-glycerophosphate was included in the reaction as a phosphatase inhibitor.
Lucifer yellow uptake and actin localization
Lucifer yellow accumulation was performed as described [40] . Cells were grown to log phase and concentrated ten-fold in fresh YPD containing lucifer yellow (8 mg/ml) and incubated for 30 min at 30°C. Stained cells were examined at a magnification of 630× using a charge-coupled device camera mounted on a Leica DM-LB microscope. Images were analyzed by using a Northern Exposure Image System (Empix Imaging). For actin localization, 15 ml of cells were grown in either YPD or YPDS (3% NaCl) to mid-log phase, and fixed by addition of 37% formaldehyde to the media to a final concentration of 4% for 20 min. Cells were harvested, resuspended in 1 ml PBS containing 4% formaldehyde, and mixed for 1 h at room temperature before washing four times with 1 ml PBS. Cells were resuspended in PBS and briefly sonicated, then 50-75 µl of the fixed cells were stained with 1/10 volume of rhodamine-phalloidin (Molecular Probes, 6.6 µM in MeOH) for 1 h at room temperature. Cells were washed five times with 1 ml PBS and resuspended in 30 µl Pro-Long antifade reagent (Molecular Probes); 5 µl of each preparation was spotted onto a slide and a coverslip was placed on top of the slide for at least 15 min before viewing. Stained cells were photographed at 600× magnification using Kodak TMAX400 film in a Nikon 35 mm camera mounted on a Nikon Microphot-FXA fluorescence microscope.
Supplementary material
A table of the yeast strains used in this study is published with this paper on the internet.
